相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunction
Peter J. Teravskis et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
Tamoxifen for amyotrophic lateral sclerosis A randomized double-blind clinical trial
Po-Chih Chen et al.
MEDICINE (2020)
mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent
Khaled S. Abd-Elrahman et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease
Michiel Van Bulck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical Trial Highlights: Targetting Alpha-Synuclein
Kevin McFarthing
JOURNAL OF PARKINSONS DISEASE (2019)
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease
Sunil S. Adav et al.
MOLECULAR BRAIN (2019)
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Archana Prasad et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy
Lara Marrone et al.
ACTA NEUROPATHOLOGICA (2019)
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Rudolf C. Hergesheimer et al.
BRAIN (2019)
Familial Alzheimer's disease-linked presenilin mutants and intracellular Ca2+ handling: A single-organelle, FRET-based analysis
Elisa Greotti et al.
CELL CALCIUM (2019)
Structural Transition, Function and Dysfunction of TDP-43 in Neurodegenerative Diseases
Tariq Afroz et al.
CHIMIA (2019)
New molecular approaches to Alzheimer's disease
Chiara Di Resta et al.
CLINICAL BIOCHEMISTRY (2019)
Amyloid- oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy
David C. Bode et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory
Walter Gulisano et al.
JOURNAL OF NEUROSCIENCE (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys et al.
MOVEMENT DISORDERS (2019)
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease
Bryan Zeitler et al.
NATURE MEDICINE (2019)
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD)
Barbara Mroczko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ageing as a risk factor for neurodegenerative disease
Yujun Hou et al.
NATURE REVIEWS NEUROLOGY (2019)
Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
Xu-Qiao Chen et al.
FRONTIERS IN NEUROSCIENCE (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease
Carmen Pena-Bautista et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
A C-terminal peptide from secreted amyloid precursor protein-α enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer's disease
Jodi A. Morrissey et al.
NEUROPHARMACOLOGY (2019)
Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis
Anushka Chakravorty et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
Yu Ding et al.
FRONTIERS IN NEUROLOGY (2019)
Secreted amyloid-β precursor protein functions as a GABABR1a ligand to modulate synaptic transmission
Heather C. Rice et al.
SCIENCE (2019)
Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis
Gregory Klein et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model
Alexandre Androuin et al.
ACTA NEUROPATHOLOGICA (2018)
Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites
Takuya Yoshizawa et al.
CELL (2018)
N-Terminal Charged Residues of Amyloid-β Peptide Modulate Amyloidogenesis and Interaction with Lipid Membrane
Clifford Morris et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease
Shohreh Majd et al.
CURRENT ALZHEIMER RESEARCH (2018)
Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease
P. Hemachandra Reddy et al.
HUMAN MOLECULAR GENETICS (2018)
Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Jessica Mandrioli et al.
MEDICINE (2018)
The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status
Walter Gulisano et al.
NEUROBIOLOGY OF AGING (2018)
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
Michael Benatar et al.
NEUROLOGY (2018)
TDP-43 causes neurotoxicity and cytoskeletal dysfunction in primary cortical neurons
Pranetha Baskaran et al.
PLOS ONE (2018)
Critical aggregation concentration for the formation of early Amyloid-β (1-42) oligomers
Mercedes Novo et al.
SCIENTIFIC REPORTS (2018)
A specific form of prefibrillar aggregates that functions as a precursor of amyloid nucleation
Naoki Yamamoto et al.
SCIENTIFIC REPORTS (2018)
Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis
Sara Sameni et al.
SCIENTIFIC REPORTS (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
Yeast as a Model to Unravel Mechanisms Behind FUS Toxicity in Amyotrophic Lateral Sclerosis
Michelle Lindstrom et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease
Priscilla Youssef et al.
SCIENTIFIC REPORTS (2018)
LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson's Disease through Activating -Synuclein Expression
Xiaonan Xu et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Importance of Functional Loss of FUS in FTLD/ALS
Shinsuke Ishigaki et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
Maria Jimenez-Sanchez et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Ralph A. Nixon
FASEB JOURNAL (2017)
Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes
Arianna Russo et al.
HUMAN MOLECULAR GENETICS (2017)
Tau deletion promotes brain insulin resistance
Elodie Marciniak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Parkinson's disease as a multisystem disorder
Lisa Klingelhoefer et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Endocytosis regulates TDP-43 toxicity and turnover
Guangbo Liu et al.
NATURE COMMUNICATIONS (2017)
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
Tariq Afroz et al.
NATURE COMMUNICATIONS (2017)
Alzheimer's disease prevention: from risk factors to early intervention
Marta Crous-Bou et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
TBK1: a new player in ALS linking autophagy and neuroinflammation
James A. Oakes et al.
MOLECULAR BRAIN (2017)
Edaravone and its clinical development for a amyotrophic lateral sclerosis
Koji Takei et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Protein misfolding in neurodegenerative diseases: implications and strategies
Patrick Sweeney et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Tarenflurbil Protection from Cytotoxicity is Associated with an Upregulation of Neurotrophins
Xu Zhao et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
Amit Berson et al.
CURRENT BIOLOGY (2017)
Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease
Adewale Adegbuyiro et al.
BIOCHEMISTRY (2017)
Phase to Phase with TDP-43
Yulong Sun et al.
BIOCHEMISTRY (2017)
TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion
Qin Xia et al.
EMBO JOURNAL (2016)
Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways
Judith M. Silverman et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons
Benjamin M. Schwenk et al.
EMBO JOURNAL (2016)
Protein aggregation and neurodegenerative diseases: From theory to therapy
Vijay Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
Simran J. Kaur et al.
GENE (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease
Matthew J. Benskey et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils
Michael T. Colvin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
The activities of amyloids from a structural perspective
Roland Riek et al.
NATURE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
Michael D. Weiss et al.
NEUROLOGY (2016)
APP Receptor? To Be or Not To Be
Carole Deyts et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
An acridine derivative, [4,5-bis {(N-carboxy methyl imidazolium) methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models
Archana Prasad et al.
SCIENTIFIC REPORTS (2016)
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Ziv Gan-Or et al.
AUTOPHAGY (2015)
Extracellular alpha-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane
Carla R. Pacheco et al.
JOURNAL OF NEUROCHEMISTRY (2015)
New Insights in Amyloid Beta Interactions with Human Telomerase
Jiasi Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Lysosomal Alterations in Peripheral Blood Mononuclear Cells of Parkinson's Disease Patients
Nikolaos Papagiannakis et al.
MOVEMENT DISORDERS (2015)
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Axel Freischmidt et al.
NATURE NEUROSCIENCE (2015)
Targeting protein aggregation for the treatment of degenerative diseases
Yvonne S. Eisele et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events
Meredith E. Jackrel et al.
CELL (2014)
Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43
Carola Stribl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death RELEVANCE TO EPIGENETIC MECHANISMS OF NEURODEGENERATION IN PARKINSON DISEASE
Huajun Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Regulation of Autophagosome Dynamics by Huntingtin and HAP1 Is Disrupted by Expression of Mutant Huntingtin, Leading to Defective Cargo Degradation
Yvette C. Wong et al.
JOURNAL OF NEUROSCIENCE (2014)
Disease-Associated Mutations of TDP-43 Promote Turnover of the Protein Through the Proteasomal Pathway
Wataru Araki et al.
MOLECULAR NEUROBIOLOGY (2014)
Trafficking regulation of proteins in Alzheimer's disease
Shangtong Jiang et al.
MOLECULAR NEURODEGENERATION (2014)
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Sami J. Barmada et al.
NATURE CHEMICAL BIOLOGY (2014)
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors
Andrea Crotti et al.
NATURE NEUROSCIENCE (2014)
Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones
J. R. Highley et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions
Marie Violet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Increased metal content in the TDP-43A315T transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Theresa N. T. Dang et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Huntingtin Regulates Mammary Stem Cell Division and Differentiation
Salah Elias et al.
STEM CELL REPORTS (2014)
Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease
Hwan-Ching Tai et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes
Claudio Canale et al.
BIOPHYSICAL CHEMISTRY (2013)
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons
Wenzhang Wang et al.
HUMAN MOLECULAR GENETICS (2013)
Mutant Huntingtin Alters Retrograde Transport of TrkB Receptors in Striatal Dendrites
Geraldine Liot et al.
JOURNAL OF NEUROSCIENCE (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Huntingtin's Function in Axonal Transport Is Conserved in Drosophila melanogaster
Diana Zala et al.
PLOS ONE (2013)
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
Eveline S. Arnold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
Andres Binolfi et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Alpha-synuclein pore forming activity upon membrane association
Laura Tosatto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
α-Synuclein misfolding and Parkinson's disease
Leonid Breydo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function
Joel A. Cassel et al.
BIOCHIMIE (2012)
Two-Step Mechanism of Membrane Disruption by Aβ through Membrane Fragmentation and Pore Formation
Michele F. M. Sciacca et al.
BIOPHYSICAL JOURNAL (2012)
Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Igor F. Tsigelny et al.
FEBS JOURNAL (2012)
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
The role of alpha-synuclein in neurotransmission and synaptic plasticity
Furong Cheng et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
α-Synuclein Negatively Regulates Protein Kinase Cδ Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase Activity
Huajun Jin et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
Xiao-dong Pan et al.
MOLECULAR NEURODEGENERATION (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Amyloid Precursor Protein Is Trafficked and Secreted via Synaptic Vesicles
Teja W. Groemer et al.
PLOS ONE (2011)
Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
Chiara Zuccato et al.
PLOS ONE (2011)
Huntington's Disease
Steven Finkbeiner
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS
Zhihui Sun et al.
PLOS BIOLOGY (2011)
Amyloid oligomers: formation and toxicity of A beta oligomers
Masafumi Sakono et al.
FEBS JOURNAL (2010)
Zinc induces depletion and aggregation of endogenous TDP-43
Aphrodite Caragounis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Huntingtin-associated Protein-1 Interacts with Pro-brain-derived Neurotrophic Factor and Mediates Its Transport and Release
Linda Lin-yan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration
David A. Scott et al.
JOURNAL OF NEUROSCIENCE (2010)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
Delivery of GABAARs to Synapses Is Mediated by HAP1-KIF5 and Disrupted by Mutant Huntingtin
Alison E. Twelvetrees et al.
NEURON (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
Bart D. van Rooijen et al.
PLOS ONE (2010)
Deficits in axonal transport precede ALS symptoms in vivo
Lynsey G. Bilsland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model
Sheng Zhang et al.
DISEASE MODELS & MECHANISMS (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Cindy M. Sondag et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2009)
α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity
Guangwei Liu et al.
NEUROSCIENCE LETTERS (2009)
Dissecting the potential molecular mechanisms underlying a-synuclein cell-to-cell transfer in Parkinson's disease
Elodie Angot et al.
PARKINSONISM & RELATED DISORDERS (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain
Latha Devi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS
Yueming Chang et al.
PLOS ONE (2008)
Differential regulation of dynein and kinesin motor proteins by tau
Ram Dixit et al.
SCIENCE (2008)
Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: Neurofilaments attenuate tau-mediated neurite instability
Maya Dubey et al.
CELL MOTILITY AND THE CYTOSKELETON (2008)
Helical α-synuclein forms highly conductive ion channels
Stanislav D. Zakharov et al.
BIOCHEMISTRY (2007)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Huntingtin facilitates dynein/dynactin-mediated vesicle transport
Juliane P. Caviston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A three-stage kinetic model of amyloid fibrillation
Chuang-Chung Lee et al.
BIOPHYSICAL JOURNAL (2007)
Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis
Shoichi Sasaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels
Agata Adamczyk et al.
NEUROREPORT (2006)
Impairment of microtubule-dependent trafficking by overexpression of α-synuclein
He-Jin Lee et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease
BI Bae et al.
NEURON (2005)
A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice
D Kieran et al.
JOURNAL OF CELL BIOLOGY (2005)
Proteasomal inhibition by α-synuclein filaments and oligomers
E Lindersson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effects of novel peptides derived from-the acidic tail of synuclein (ATS) on the aggregation and stability of fusion proteins
SM Park et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Trypsin disrupts the trafficking of the human dopamine transporter by α-synuclein and its A30P mutant
C Wersinger et al.
BIOCHEMISTRY (2004)
Inefficient degradation of truncated polyglutamine proteins by the proteasome
CI Holmberg et al.
EMBO JOURNAL (2004)
Increased lipid peroxidation in sera of ALS patients - A potential biomarker of disease burden
EP Simpson et al.
NEUROLOGY (2004)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
Wild-type huntingtin plays a role in brain development and neuronal survival
A Reiner et al.
MOLECULAR NEUROBIOLOGY (2003)
Golgi fragmentation occurs in the cells with prefibrillar α-synuclein aggregates and precedes the formation of fibrillar inclusion
N Gosavi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mitochondrial respiratory chain function in skeletal muscle of ALS patients
A Echaniz-Laguna et al.
ANNALS OF NEUROLOGY (2002)
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2002)
Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism
MJ Volles et al.
BIOCHEMISTRY (2002)
Stress-induced aggregation profiles of GST-α-synuclein fusion proteins:: Role of the C-terminal acidic tail of α-synuclein in protein thermosolubility and stability
SM Park et al.
BIOCHEMISTRY (2002)
Tubulin seeds α-synuclein fibril formation
MA Alim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis
MJ Chung et al.
ULTRASTRUCTURAL PATHOLOGY (2002)
Vesicle permeabilization by protofibrillar α-synuclein:: Implications for the pathogenesis and treatment of Parkinson's disease
MJ Volles et al.
BIOCHEMISTRY (2001)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
Y Tanaka et al.
HUMAN MOLECULAR GENETICS (2001)
Proteasomal function is impaired in substantia nigra in Parkinson's disease
KSP McNaught et al.
NEUROSCIENCE LETTERS (2001)
α-synuclein promotes mitochondrial deficit and oxidative stress
LJ Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
